Register Now: IKRIS Breast Cancer Awareness Run 2022

Tag Archives: RRMM medicine

Teclistamab Shows High Response Rate and Good Tolerability Profile in Patients with Multiple Myeloma

According to outcomes from an ongoing study presented during the II’nd European Myeloma Network Meeting, Teclistamab shows high response rate […]

ikrisuser
April 21, 2021